The FDA just gave extended approval for Ocular Therapeutix’s post-op eye drug The shares of Ocular Therapeutix Inc (NASDAQ:OCUL) are making a comeback today, after the drugmaker announced that the …

More Penny Stock Picks Up FDA Nod Videos